Wegovy (semaglutide) and Mounjaro (tirzepatide) are both injectable medications used for weight management.
Both are taken once weekly, but they work in slightly different ways, which can affect how much weight you lose, and the side effects you might experience.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Mechanism | Targets one hormone: GLP-1 (glucagon-like peptide-1) | Targets two hormones: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) |
| Active ingredient | Semaglutide | Tirzepatide |
| How it works | Slows digestion, reduces appetite, helps control blood sugar | Reduces appetite, improves blood-sugar control, may offer stronger metabolic effects |
| Average weight loss | Around 19-21% of body weight over 72 weeks | Around 20%–22.5% of body weight over 72 weeks |
| Dosing schedule | Weekly injection | Weekly injection |
| Starting dose | 0.25mg | 2.5mg |
| Dose escalation | Monthly, up to 2.4mg or 7.2mg | Gradual, up to 15mg |
| Most common side effects | Nausea, bloating, diarrhoea, constipation | Nausea, reduced appetite, constipation, stomach discomfort |
| Cost | From £93.99 | From £143.99 |
| Cardiovascular benefits | Proven to reduce the risk of heart attack, stroke, and cardiovascular death by up to 20% | Ongoing trials, but no official data yet (early signs suggest promise) |
| Approval | Approved in the UK for weight loss | Approved in the UK for weight loss |
Both medicines help with weight loss by reducing appetite and helping you feel full sooner. The key difference is how many “signals” in the body they act on.
Wegovy works by copying a one natural hormone in your body called GLP-1.
In simple terms, it:
Think of Wegovy as one strong signal that reduces appetite and helps you eat less.
Mounjaro works on two natural hormones: GLP-1 and GIP.
It does everything Wegovy does and more:
You can think of Mounjaro as sending two signals instead of one, which is why many people lose more weight on it.
| Wegovy | Mounjaro | |
|---|---|---|
| Hormones it works on | GLP-1 only | GLP-1 + GIP |
| Appetite control | Strong | Very strong |
| Feeling full for longer | Yes | Yes |
| Effect on metabolism | Moderate | Stronger |
| Typical weight-loss results | Very good | Often greater |
Bottom line
When we look at studies that directly compare the two medicines, Mounjaro generally leads to more weight loss than Wegovy.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Average weight loss | ~19/21%% of starting body weight | ~18–22.5% of starting body weight |
| Patients losing ≥20% | ~30–35% | ~45–55% |
| Best overall effectiveness | Strong | Stronger |
| Conclusion on effectiveness | Very effective | More effective than Wegovy |
Mounjaro generally leads to more weight loss than Wegovy.
Nearly half (or more) of people on Mounjaro hit ≥20% weight loss, significantly higher than Wegovy.
Bottom line
Mounjaro is generally more effective than Wegovy in terms of actual weight lost and the number of patients achieving large weight reductions.
Both medications are effective, but Mounjaro produced better results in clinical trials when used at appropriate doses for weight management.
Wegovy and Mounjaro both act on similar gut hormones, therefore many of their side effects, especially gastrointestinal symptoms like nausea, vomiting, and diarrhoea, are similar.
| Side effect | Wegovy (semaglutide) | Mounjaro (tirzepatide) | What this means for patients |
|---|---|---|---|
| Nausea | Very common | Common | Feeling sick is the most frequent side effect, especially when starting or increasing dose. |
| Vomiting | Common | Common | May occur early on but usually settles as the body adjusts. |
| Diarrhoea | Common | Common | Loose stools or urgency can happen, particularly in the first few weeks. |
| Constipation | Common | Uncommon | Some people may become constipated, more often with Wegovy. |
| Indigestion / bloating | Common | Common | A feeling of fullness, reflux, or discomfort after eating. |
| Reduced appetite | Very common | Very common | Both medicines strongly reduce hunger, which helps with weight loss. |
| Headache / dizziness | Uncommon | Uncommon | Usually mild and temporary. |
| Gallbladder problems | Rare | Rare | Can occur with rapid weight loss rather than the drug itself. |
| Pancreatitis | Rare | Rare | Serious but uncommon; seek medical help for severe abdominal pain. |
Further reading: Mounjaro Side Effects
Further reading: Wegovy Side Effects
Bottom line
When comparing Wegovy and Mounjaro, the cost difference can be substantial. Wegovy tends to be cheaper over a year, especially once maintenance doses are reached.
Although Mounjaro may produce slightly greater average weight loss of up to 22.5% compared to 17% with Wegovy, this potential benefit is associated with a higher treatment cost.
| Wegovy | Price | Mounjaro | Price | Saving |
|---|---|---|---|---|
| 0.25mg | £93.99 | 2.5mg | £143.99 | Saving £50 with Wegovy |
| 0.5mg | £97.99 | 5mg | £153.99 | Saving £56 with Wegovy |
| 1mg | £107.99 | 7.5mg | £212.99 | Saving £105 with Wegovy |
| 1.7mg | £136.99 | 10mg | £239.99 | Saving £103 with Wegovy |
| 2.4mg | £175.99 | 12.5mg | £259.99 | Saving £84 with Wegovy |
| 7.2mg | £552.40 | 15mg | £279.49 | Losing £272.91 with Wegovy |
Further reading: Switching from Mounjaro to Wegovy
Bottom line
Both Wegovy and Mounjaro are increased gradually over time, which helps your body adjust and reduces the chance of stomach-related side effects.
This step-by-step approach makes treatment safer and easier to tolerate.
The chart below shows how the doses are increased over time, making it easier for you to choose the right starting point and long-term dose for safe, effective weight-loss treatment.
| Feature | Wegovy (semaglutide) | Mounjaro (tirzepatide) |
|---|---|---|
| Starting dose | 0.25mg once weekly | 2.5mg once weekly |
| Dose escalation | Increases every 4 weeks | Increases every 4 weeks |
| Dose increases | 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg → 7.2mg | 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg |
| Maintenance dose | 2.4mg or 7.2mg weekly | 5–15mg weekly (dose depends on response and tolerability) |
| Typical time to reach full dose | 20-24 weeks | 24 weeks |
| Pen strength options | Multi-dose (4) single strength pens | Multi-dose (4) single strength pens |
Bottom line
The best choice depends on your individual health needs, weight-loss goals, cost, and a discussion with your healthcare provider.
Wegovy may be right for you if:
*It is important to note that meaningful cost savings are generally seen only up to a maintenance dose of 2.4mg, which is associated with average weight loss of up to 17%. For the higher dose of Wegovy 7.2mg (associated with an average weight loss of 19-21%, Wegovy is more expensive than Mounjaro 15mg, which has an average weight loss potential of up to 22.5%).
Mounjaro may be right for you if:
Bottom line
Both medications work best when combined with a reduced-calorie diet and increased physical activity as part of a structured weight-management plan.
Always speak with a healthcare professional to decide which option is most suitable for you.
Neither medicine is universally “better”; the choice depends on your clinical needs.
In terms of greater average weight loss, Mounjaro produces better results.
Further reading: Mounjaro results
Wegovy is generally less expensive than Mounjaro because of differences in pricing strategies and market factors.
*This only applies to Wegovy 0.5mg to 2.4mg.
Wegovy 7.2mg which is the most effective dose, is more expensive than the most effective dose of Mounjaro (15mg)
Both Wegovy and Mounjaro are weight loss injections, but they work slightly differently.
Wegovy targets the GLP‑1 receptor, while Mounjaro targets both GLP‑1 and GIP receptors, which can lead to greater average weight loss.
Both treatments have a demonstrated track record and a good safety profile.
For more information, you can read our articles:
Whilst all of our content is written and reviewed by healthcare professionals, it is not intended to be substituted for or used as medical advice. If you have any questions or concerns about your health, please speak to your doctor.